BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29780602)

  • 1. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
    Liao Y; Li S; Chen C; He X; Lin F; Wang J; Yang Z; Lan P
    Gastroenterol Rep (Oxf); 2018 May; 6(2):132-136. PubMed ID: 29780602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.
    Li JB; Qiu ZY; Deng YX; Li Y; Lin ZC; Wu YP; Weng F; Tian H; Ou QJ; Gong CH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Discov Oncol; 2022 Jan; 13(1):4. PubMed ID: 35201502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.
    Zhang M; Zhao L; Zhang Y; Jing H; Wei L; Li Z; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Front Oncol; 2022; 12():893183. PubMed ID: 35712520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
    Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
    Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.
    Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C
    Clin Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38325601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
    Dong X; Du L; Luo Z; Xu Y; Wang C; Wang F; Cao W; Zhao L; Zheng Y; Zhu H; Xia C; Li J; Du M; Hang D; Ren J; Shi J; Shen H; Chen W; Li N; He J;
    PLoS Med; 2024 Feb; 21(2):e1004340. PubMed ID: 38386617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China.
    Lin G; Feng Z; Liu H; Li Y; Nie Y; Liang Y; Li K
    Sci Rep; 2019 Jul; 9(1):10424. PubMed ID: 31320661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.
    Cai SR; Huang YQ; Zhang SZ; Li QR; Ma XY; Zheng S
    BMC Cancer; 2019 Jan; 19(1):47. PubMed ID: 30630450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population.
    Zhu Y; Zhao G; Ma W; Chen X; Chen X; Li D; Zhao S; Xiong S; Zheng M
    Cancer Med; 2023 Apr; 12(7):7689-7698. PubMed ID: 36468523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program.
    Ye D; Huang Q; Li Q; Jiang X; Mamat M; Tang M; Wang J; Chen K
    Dig Dis Sci; 2017 Sep; 62(9):2532-2541. PubMed ID: 28634645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer.
    Moosavi S; Gentile L; Gondara L; Mcgahan C; Enns RA; Telford J
    J Can Assoc Gastroenterol; 2020 Dec; 3(6):288-292. PubMed ID: 33241182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.